Retinoic acid inhibits tissue factor and HMGB1 via modulation of AMPK activity in TNF-α activated endothelial cells and LPS-injected mice
- 1 August 2015
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 241 (2) , 615-623
Abstract
No abstract availableKeywords
Funding Information
- Research Foundation of Korea (NRF2013R1A1A2058604)
This publication has 35 references indexed in Scilit:
- HMGB1 Expression and Secretion Are Increased Via TWEAK–Fn14 Interaction in Atherosclerotic Plaques and Cultured MonocytesArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Tissue factor–protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammationNature Medicine, 2011
- Metformin inhibits HMGB1 release in LPS‐treated RAW 264.7 cells and increases survival rate of endotoxaemic miceBritish Journal of Pharmacology, 2010
- Metformin inhibits P‐glycoprotein expression via the NF‐κB pathway and CRE transcriptional activity through AMPK activationBritish Journal of Pharmacology, 2010
- Acadesine Inhibits Tissue Factor Induction and Thrombus Formation by Activating the Phosphoinositide 3-Kinase/Akt Signaling PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Cellular sources of tissue factor in endotoxemia and sepsisThrombosis Research, 2010
- Vascular Functions of the Plasminogen Activation SystemArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Function and regulation of the complement system in cardiovascular diseasesFrontiers in Bioscience-Landmark, 2007
- Thrombotic Microangiopathic Glomerulopathy in Human Decay Accelerating Factor–Transgenic Swine-to-Baboon Kidney XenograftsJournal of the American Society of Nephrology, 2005
- Transcriptional Regulation of Tissue Factor Expression in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1995